A Phase 1 Open-Label Fixed-Sequence Two-Period Crossover Study Of The Effect Of Multiple Doses Of Tamoxifen On PD-0332991 Pharmacokinetics In Healthy Male Volunteers
Phase of Trial: Phase I
Latest Information Update: 09 Apr 2014
At a glance
- Drugs Palbociclib (Primary) ; Tamoxifen (Primary)
- Indications Breast cancer; Colorectal cancer; Glioblastoma; Liposarcoma; Mantle-cell lymphoma; Multiple myeloma; Solid tumours
- Focus Pharmacokinetics
- Sponsors Pfizer
- 09 Apr 2014 Results presented at the 105th Annual Meeting of the American Association for Cancer Research.
- 13 Aug 2013 Planned End Date changed from 1 Jul 2013 to 1 Aug 2013 as reported by ClinicalTrials.gov.
- 01 Aug 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.